4//SEC Filing
Howe Roger J 4
Accession 0000914190-09-000238
CIK 0001222929other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 7:08 PM ET
Size
21.5 KB
Accession
0000914190-09-000238
Insider Transaction Report
Form 4
Howe Roger J
Director
Transactions
- Disposition to Issuer
Common Stock
2009-02-25−41,500→ 0 total(indirect: By Partnership) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−20,000→ 0 total→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−20,000→ 0 total→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−6,680→ 0 total→ Common Stock (6,680 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−23,320→ 0 total→ Common Stock (23,320 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−187,775→ 0 total→ Common Stock (187,775 underlying) - Disposition to Issuer
Warrant
2009-02-25−13,000→ 0 total(indirect: By Partnership)→ Common Stock (13,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2009-02-25−15,000→ 0 total→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to a merger agreement among the issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each share of the issuer's common stock was converted into 0.647 shares of common stock of Replidyne, Inc.
- [F2]Shares and warrants held by Sonora Web LLLP, of which Dr. Howe is the General Partner.
- [F3]Disposed of pursuant to a merger agreement among issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each of the issuer's stock options was assumed by Replidyne, Inc. and became exercisable to purchase shares of Replidyne, Inc. common stock; each share covered by the issuer's options was converted into 0.647 shares of common stock of Replidyne, Inc., and the exercise price of each option was adjusted by dividing the pre-merger exercise price by 0.647 and rounding up to the nearest cent.
- [F4]Disposed of pursuant to a merger agreement among the issuer, Responder Merger Sub, Inc. and Replidyne, Inc. (now known as "Cardiovascular Systems, Inc."), pursuant to which each of the issuer's common stock warrants was assumed by Replidyne, Inc. and became exercisable to purchase shares of Replidyne, Inc. common stock; each share covered by the issuer's common stock warrants was converted into 0.647 shares of common stock of Replidyne, Inc., and the exercise price of each warrant was adjusted by dividing the pre-merger exercise price by 0.647 and rounding up to the nearest cent.
Documents
Issuer
CARDIOVASCULAR SYSTEMS INC
CIK 0001222929
Entity typeother
Related Parties
1- filerCIK 0001428728
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 7:08 PM ET
- Size
- 21.5 KB